A retrospective study evaluating efficacy of nivolumab in patients with clear cell metastatic renal carcinoma

Trial Profile

A retrospective study evaluating efficacy of nivolumab in patients with clear cell metastatic renal carcinoma

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Mar 2018

At a glance

  • Drugs Nivolumab (Primary)
  • Indications Renal cell carcinoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Mar 2018 New trial record
    • 10 Feb 2018 Results assessing the patterns of disease progression in nivolumab treated metastatic renal cell carcinoma patients presented at the 2018 Genitourinary Cancers Symposium
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top